NFLIS Releases 2018 Annual Report

The National Forensic Laboratory Information System — a program of the Drug Enforcement Administration — has released its 2018 NFLIS-Drug Annual Report. The publication provides a comprehensive look at the results of all drug cases submitted to state and local laboratories from January 1, 2018 through December 31, 2018 and analyzed by March 31, 2019.

Highlights from this time period include:

An estimated 933,390 distinct drug cases were submitted and analyzed in the timeframe described above. From those cases, an estimated 1,599,428 drug reports were identified.

Methamphetamine was the most frequently identified drug with more than 386,000 reports in 2018, followed by cannabis/THC (344,489 reports), cocaine (228,924 reports), and heroin (140,818).

Between 2017 and 2018, reports of fentanyl and buprenorphine increased significantly, while reports of alprazolam, oxycodone, and hydrocodone decreased significantly.

In 2018, fentanyl accounted for 45% of narcotic analgesic reports. Alprazolam accounted for 58% of the reports of identified tranquilizers and depressants. Among identified synthetic cannabinoids, 5F-ADB and FUB-AMB accounted for 69% of reports.

You can download the entire report as a PDF here.

Next >

Court Case Update

FINGERPRINT EVIDENCE went through a nearly three-year ordeal in the New Hampshire court system, but eventually emerged unscathed. On April 4, 2008, the New Hampshire Supreme Court unanimously reversed the decision of a lower court to exclude expert testimony regarding fingerprint evidence in the case of The State of New Hampshire v. Richard Langill. The case has been remanded back to the Rockingham County Superior Court.